Advertisement

Topics

Diagnostica Longwood s.l Company Profile

05:09 EDT 20th June 2018 | BioPortfolio

Desde 1992 Diagnostica Longwood s.l, distribuidor en exclusiva de varias compañias internacionales, ofrece a sus clientes una amplia gama de productos para diagnóstico e investigación en laboratorios de Inmunología, Transplante, Genética y Bancos de sangre. Nuestro principal objetivo es la satisfacción de nuestros clientes, para quienes ofrecemos una rápida gestión de sus solicitudes, productos de máxima calidad y un soporte técnico gestionado por personal altamente cualificado y especializado.

Contact

Phone: 976 320 638
Fax: 976 320 660
Email: e-mail_dlw@dlongwood.com


News Articles [15 Associated News Articles listed on BioPortfolio]

#jobs #lifescience Longwood Medical Area: Research Fellow

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Longwood Medical Area: Research Fellow . Depends on Experience: Longwood Medi...

#jobs #lifescience Longwood Medical Area: Research Fellow – Breast Immunology Laboratory

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Longwood Medical Area: Research Fellow – Breast Immunology Laboratory ....

Orion to investigate possible sale of Orion Diagnostica

ORION CORPORATION         STOCK EXCHANGE RELEASE   23 JANUARY 2018 at 12.20. p.m. EET          Orion to investigate possible sale of Orion Diagnostica Orion Cor...

Orion has completed the sale of Orion Diagnostica business division

ORION CORPORATION         PRESS RELEASE                30 April 2018 at 12.15 p.m. Orion has completed the sale of Orion Diagnostica business division Orion C...

Akers Biosciences Signs US Distribution Agreement with Diagnostica Stago

THOROFARE, N.J., March 26, 2018 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (“Akers Bio” or the "Company"), a developer of rapid health information technologies, ...

ArcherDX brings in $35mm Series A round

ArcherDX Inc. (next-generation sequencing (NGS) gene fusion detection assays) raised $35mm through a Series A round co-led by Boulder Ventures (added a board member) and PBM Capital Group. New investo...

Orion to divest diagnostics business for up to $272M

An agreement was reached by Orion to sell its diagnostics business, Orion Diagnostica, to an Axcel Management-led investment  -More- 

Orion to sell its Orion Diagnostica division - Due to the transaction Orion updates its outlook

ORION CORPORATION         STOCK EXCHANGE RELEASE   21 APRIL 2018     at  01.30  a.m. EEST         Orion to sell its Orion Diagnostica di...

Drugs and Medications [0 Results]

None

PubMed Articles [17 Associated PubMed Articles listed on BioPortfolio]

The treatment of latent TB infection in HIV-positive people: the Verona experience.

Not available.

Trombiculiasis: an underreported ectoparasitosis in Sicily.

Trombiculiasis is a common but underreported ectoparasitosis characterized by an infestation of the skin by the larval stage of various species of mites belonging to the phylum Arthropoda, class Arach...

Spanish flu in Italy: new data, new questions.

This paper proposes a new estimate for the number of victims of Spanish flu in Italy and highlights some aspects of mortality closely linked to the First World War. The sources used are official death...

Giardiasis and subsequent diagnosis of HIV infection in a patient with persistent diarrhoea: a case report.

Although its prevalence in resource-rich countries is not precisely estimated, persistent diarrhoea is not a common event if extreme ages are excluded. Enteric pathogens, of various underlying aetiolo...

Respiratory syncytial virus bronchiolitis and hypertransaminasemia.

Bronchiolitis is the most common disease of the lower respiratory tract occurring in children during their first year of life, becoming the most frequent cause of hospitalization. Although the disease...

Clinical Trials [1 Associated Clinical Trials listed on BioPortfolio]

Impact of Rapid Pathogen Identification From Blood Cultures

Septic shock carries high mortality, which may be exacerbated by inappropriate initial therapy. Inappropriate therapy may result from unanticipated antimicrobial resistance. Conversely, po...

Companies [15 Associated Companies listed on BioPortfolio]

Diagnostica Longwood s.l

Desde 1992 Diagnostica Longwood s.l, distribuidor en exclusiva de varias compañias internacionales, ofrece a sus clientes una amplia gama de productos para diagnóstico e investigación en laboratori...

Longwood Founders Fund, L.P.

Longwood Founders Fund is a healthcare venture capital firm that founds, manages, and builds biotechnology companies. Longwood’s mission is to identify technologies and to fo...

Stago

With a staff of close to 1,500 and the most advanced technologies, Diagnostica Stago formulates,manufactures and markets worldwide, the broadest range of reagents and analytical instruments in haemost...

STAT-Diagnostica

Founded in 2010 in Barcelona, STAT-Diagnostica is focused on the development of Near Patient Testing solutions where fast and accurate diagnostic results are needed. Its in vitro ...

Orion Diagnostica Oy

Orion Diagnostica Oy is a biomedical company belonging to the Orion Group, the leading health-care company in Finland. Established in 1974, Orion Diagnostica specialises in rapid and easy-to-use clini...

More Information about "Diagnostica Longwood s.l" on BioPortfolio

We have published hundreds of Diagnostica Longwood s.l news stories on BioPortfolio along with dozens of Diagnostica Longwood s.l Clinical Trials and PubMed Articles about Diagnostica Longwood s.l for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Diagnostica Longwood s.l Companies in our database. You can also find out about relevant Diagnostica Longwood s.l Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record